• Who We Are
    • Survey Research Unit
  • Our Scientists
  • What We Do
  • Research Projects
    • Research Projects
    • Solutions Networks
  • Events
    • Events
    • 2023 Symposium
    • Summer Student Program
    • Community Scholar Initiative
  • News
  • Podcasts
Skip to content
MAP Centre for Urban Health Solutions
  • Français
Contact Us Donate
Search
Generic filters
Exact matches only
  • Who We Are
    • Survey Research Unit
  • Our Scientists
  • What We Do
  • Research Projects
    • Research Projects
    • Solutions Networks
  • Events
    • Events
    • 2023 Symposium
    • Summer Student Program
    • Community Scholar Initiative
  • News
  • Podcasts
placeholder

Groundbreaking advancements in HIV treatment and prevention

In this podcast from CMAJ, Dr. Darrell Tan describes the regimen of the newly approved long-acting injectable for pre-exposure prophylaxis and as a treatment for HIV.

Listen here

Related:

  • “A game changer”: Dual HIV-Syphilis rapid test approved for use in Canada
  • Long-acting injectable PrEP is a big step forward in HIV prevention
  • Can HIV self-tests help counter Canada’s rising transmission rates?
Print-friendly Version
Share Article

MAP Scientists:

  • Dr. Darrell Tan
Source: CMAJ
Share This News Article

Subscribe to the MAP Junction Newsletter

Sign up to get our research findings, updates, publications and stories straight to your inbox.

Follow us

Together, we can build the world's healthiest city

Donate
  • News
  • Contact Us
  • For MAP Staff/Scientists
  • Terms of Use
  • St. Michael’s Hospital
  • Li Ka Shing Knowledge Institute
  • St. Michael’s Foundation
  • Survey Research Unit

Copyright 2025 MAP

Please upgrade your browser

The browser you are on will not provide an optimal experience for this website. We recommend you use Chrome, Firefox or Safari when browsing this site